Lead exposure and spine bone mineral density

Journal of Occupational and Environmental Medicine

Volumn 48, Issue 6, 2006, Pages 556-564

  Potula, Vijayalakshmi ^a,c   Kleinbaum, David ^b   Kaye, Wendy ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b EMORY UNIVERSITY   (United States)

^c AGENCY FOR TOXIC SUBSTANCES AND DISEASE REGISTRY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GRAPHITE; LEAD;

ADULT; AGED; ARTICLE; ATOMIC ABSORPTION SPECTROMETRY; BONE DENSITOMETRY; BONE DENSITY; BONE LEVEL; CONTROLLED STUDY; FEMALE; HUMAN; LEAD BLOOD LEVEL; MAJOR CLINICAL STUDY; MENOPAUSE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; OCCUPATIONAL EXPOSURE; OCCUPATIONAL HAZARD; QUESTIONNAIRE; RISK FACTOR; SEX DIFFERENCE; SMELTER; SPINE; UNITED STATES;

ADULT; BONE DENSITY; FEMALE; HUMANS; LEAD; LINEAR MODELS; MIDDLE AGED; MINING; OCCUPATIONAL EXPOSURE; SPINE;

EID: 33745187591     PISSN: 10762752     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.jom.0000222556.89044.90     Document Type: Article

References (58)

1. Davis JM, Elias RW, Grant LD. Current issues in human lead exposure and regulation of lead. Neurotoxicology. 1993;14:15-27.
2. Grandjean P. International perspectives of lead exposure and lead toxicity. Neurotoxicology. 1993;14:9-14.
3. Pounds JG. Effects of lead intoxication on calcium homeostasis and calcium-mediated cell function: a review. Neurotoxicology. 1984;5:295-332.
4. Bronner F. Bone and calcium homeostasis. Neurotoxicology. 1992;13:775-782.
5. Berglund M, Akesson A, Bjellerup P, Vahter M. Metal-bone interactions. Toxicol Lett. 2000;112-113:219-225.
6. Schwartz J, Angle C, Pitcher H. Relationship between childhood blood lead levels and stature. Pediatrics. 1986;77:11281-11288.
7. Bjora R, Falch JA, Staaland H, Nordsletten L, Gjengedal E. Osteoporosis in the Norwegian moose. Bone. 2001;29:70-73.
8. Skerfving S, Ahlgren L, Christoffersson JO, Haeger-Aronsen B, Mattsson S, Schutz A. Metabolism of inorganic lead in occupationally exposed humans. Arhiv Za Higijenu Rada i Toksikologiju. 1983;34:341-350.
9. Ericson JE, Shirahata H, Patterson CC. Skeletal concentrations of lead in ancient Peruvians. N Engl J Med. 1979;300:946-951.
10. Gross SB, Pfitzer EA, Yeager DW, Kehoe RA. Lead in human tissues. Toxicol Appl Pharmacol. 1975;32:638-651.
11. Gerhardsson L, Attewell R, Chettle DR, et al. In vivo measurements of lead in bone in long-term exposed lead smelter workers. Arch Environ Health. 1993;48:147-156.
12. Berlin K, Gerhardsson L, Borjesson J, et al. Lead intoxication caused by skeletal disease. Scand J Work Environ Health. 1995;1:296-300.
13. Skerfving S, Nilsson U, Schutz A, Gerhardsson L. Biological monitoring of inorganic lead. Scand J Work Environ Health. 1993;19(suppl 1):59-64.
14. Hu H, Rabinowitz M, Smith D. Bone lead as a biological marker in epidemiologic studies of chronic toxicity: conceptual paradigms. Environ Health Perspect. 1998;106:1-8.
15. Mosekilde L, Mosekilde L. Sex differences in age-related changes in vertebral body size, density, and biochemical competence in normal individuals. Bone. 1990;11:67-73.
16. Genant HK, Gordan GS, Hoffman PG Jr. Osteoporosis I. Advanced radiologic assessment using quantitative computed tomography. West J Med. 1983;139:75-84.
17. Gilsanz V, Boechat MI, Gilsanz R, Loro ML, Roe TF, Goodman WG. Gender differences in vertebral size in adults: biomechanical implications. Radiology. 1994;190:678-683.
18. Silbergeld EK, Schwartz J, Mahaffey K. Lead and osteoporosis: mobilization of lead from bone in women. Environ Res. 1988;47:79-94.
19. Osterloh JD, Kelly TJ. Study of the effect of lactational bone loss on blood lead concentrations in humans. Environ Health Perspect. 1991;7:187-194.
20. Sowers MR, Scholl TO, Hall G, et al. Lead in breast milk and maternal bone turnover. Am J Obstet Gynecol. 2002;187:770-776.
21. Review of Worker Exposures and Health Evaluations at the Bunker Hill Facility, Kellogg, Idaho. Washington, DC: US Environmental Protection Agency; 1992.
22. Study of Female Former Workers at a Lead Smelter: An Examination of the Possible Association of Lead Exposure With Decreased BMD and Other Health Outcomes. Atlanta: US Department of Health and Human Services; 1997. Publication No. PB97-144844.
23. Armstrong BK, White E, Saracci R. Principles of Exposure Measurement in Epidemiology. New York: Oxford University Press; 1992.
24. Wahner HW, Fogelman I. Total body bone mineral and body composition by absorptiometry. In: Fogelman I, ed. The Evaluation of Osteoporosis: Dual Energy X-Ray Absorptiometry in Clinical Practice. London: Martin Dunitz; 1994:196-218.
25. Midwest Research Institute. Lead Body Burden as a Predictor of Bone Demineralization in Women, Kellogg, Idaho. MRI project No. 104880.1.006; May 22, 2001.
26. Todd AC, McNeill FE, Fowler BA. In vivo x-ray fluorescence of lead in bone. Environ Res. 1992;59:326-335.
27. Gordon CL, Chettle DR, Webber CE. An improved instrument for the in vivo detection of bone lead. Br J Ind Med. 1993;50:637-641.
28. Stokes L, Letz R, Gerr F, et al. Neurotoxicity in young adults 20 years after childhood exposure to lead: the Bunker Hill experience. Occup Environ Med. 1998;55:507-516.
29. Burger DE, Milder FL, Morsillo PR, et al. Automated bone lead analysis by K-x-ray fluorescence for the clinical environment. Basic Life Sci. 1990;55:287-292.
30. Hu H, Milder FL, Burger DE. X-ray fluorescence measurements of lead burden in subjects with low-level community lead exposure. Arch Environ Health. 1990;45:335-341.
31. Kim R, Aro A, Rotnitzky A, et al. K X-ray fluorescence measurements of bone lead concentration: the analysis of low-level data. Phys Med Biol. 1995;40:1475-1485.
32. Nash D, Magder L, Lustberg M, et al. Blood lead, blood pressure, and hypertension in perimenopausal and postmenopausal women. JAMA. 2003;289:1523-1532.
33. Escribano A, Revilla M, Hernandez ER, et al. Effect of lead on bone development and bone mass: a morphometric, densitometric, and histomorphometric study in growing rats. Calcif Tissue Int. 1997;60:200-203.
34. Gruber HE, Gonick HC, Khalil-Manesh F, et al. Osteopenia induced by long-term, low- and high-level exposure of the adult rat to lead. Mineral and Electrolyte Metabolism. 1997;23:65-73.
35. Garrido LF, Hernandez-Avila M, Tamayo OJ, et al. Relationship of blood and bone lead to menopause and BMD among middle-age women in Mexico City. Environ Health Perspect. 2003;111:631-636.
36. Slemenda C, Longcope C, Peacock M, Hui S, Johnston CC. Sex steroids, bone mass, and bone loss. A prospective study of pre-, peri-, and postmenopausal women. J Clin Invest. 1996;97:14-21.
37. Slemenda CW, Hui SL, Longcope CL, Johnston CC. Sex steroids and bone mass: a study of changes about the time of menopause. J Clin Invest. 1987;80:1261-1269.
38. Nash D, Magder LS, Sherwin R, Rubin RJ, Silbergeld EK. Bone density-related predictors of blood lead level among peri- and postmenopausal women in the United States: the Third National Health and Nutrition Examination Survey, 1988-1994. Am J Epidemiol. 2004;160:901-911.
39. Gulson B, Mizon K, Smith H, et al. Skeletal lead release during bone resorption: effect of bisphosphonate treatment in a pilot study. Environ Health Perspect. 2002;110:1017-1023.
40. Campbell JR, Rosier RN, Novotny L, Puzas JE. The association between environmental lead exposure and bone density in children. Environ Health Perspect. 2004;112:1200-1203.
41. Hu H, Hashimoto D, Besser M. Levels of lead in blood and bone of women giving birth in a Boston hospital. Arch Environ Health. 1996;1:52-58.
42. Hernandez-Avila M, Gonzalez-Cossio T, Palazuelos E, et al. Dietary and environmental determinants of blood and bone lead levels in lactating post-partum women living in Mexico City. Environ Health Perspect. 1996;104:1076-1082.
43. Watanabe H, Hu H, Rotnitzky A. Correlates of bone and blood lead levels in carpenters. Am J Ind Med. 1994;26:255-264.
44. Somervaille LJ, Chettle DR, Scott MC, et al. In vivo tibia lead measurements as an index of cumulative exposure in occupationally exposed subjects. Br J Ind Med. 1988;45:174-181.
45. Brito JA, McNeill FE, Stronach I, et al. Longitudinal changes in bone lead concentration: implications for modelling of human bone lead metabolism. J Environ Monit. 2001;3:343-351.
46. Webber CE, Chettle DR, Bowins RJ, et al. Hormone replacement therapy may reduce the return of endogenous lead from bone to the circulation. Environ Health Perspect. 1995;103:1150-1153.
47. Eastell R. Treatment of postmenopausal osteoporosis. N Engl J Med. 1998;338:736-746.
48. The Writing Group for the PEPI. Effects of hormone therapy on BMD: results from the Postmenopausal Estrogen/Progestin Interventions (PEPI) trial. JAMA. 1996;276:1389-1396.
49. Lufkin EG, Wahner HW, O'Fallon WM, et al. Treatment of postmenopausal osteoporosis with transdermal estrogen. Ann Intern Med. 1992;117:1-9.
50. Recker RR, Davies KM, Dowd RM, et al. The effect of low-dose continuous estrogen and progesterone therapy with calcium and vitamin D on bone in elderly women. A randomized, controlled trial. Ann Intern Med. 1999;130:897-904.
51. Nguyen TV, Sambrook PN, Eisman JA. Bone loss, physical activity, and weight change in elderly women: the Dubbo Osteoporosis Epidemiology Study. J Bone Miner Res. 1998;13:1458-1467.
52. Mickelson KE, Petra PH. A filter assay for the sex steroid binding protein of human serum. FEBS Lett. 1974;44:34-38.
53. Cochran WG. Errors of measurement in statistics. Technometrics. 1968;10:637-666.
54. Pounds GJ, Long GJ, Rosen JF. Cellular and molecular toxicity of lead in bone. Environ Health Perspect. 1991;91:17-32.
55. Pounds JG, Rosen JF. Cellular metabolism of lead: a kinetic analysis in cultured osteoclastic bone cells. Toxicol Appl Pharmacol. 1986;83:531-545.
56. Long GJ, Rosen JF, Pounds JG. Cellular lead toxicity and metabolism in primary and clonal osteoblastic bone cells. Toxicol Appl Pharmacol. 1990;102:346-361.
57. Fullmer CS. Intestinal interactions of lead and calcium. Neurotoxicology. 1992;13:799-807.
58. Puzas JE, Sickel MJ, Felter ME. Osteoblasts and chondrocytes are important target cells for the toxic effects of lead. Neurotoxicology. 1992;13:783-788.